nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ABCB1—Vismodegib—skin cancer	0.149	0.557	CbGbCtD
Lisinopril—ABCB1—Dactinomycin—skin cancer	0.0783	0.292	CbGbCtD
Lisinopril—ABCB1—Docetaxel—skin cancer	0.0404	0.151	CbGbCtD
Lisinopril—ACE—forelimb zeugopod—skin cancer	0.0351	0.188	CbGeAlD
Lisinopril—ACE—forelimb—skin cancer	0.0177	0.0944	CbGeAlD
Lisinopril—ACE—hindlimb—skin cancer	0.0159	0.085	CbGeAlD
Lisinopril—ACE—arm—skin cancer	0.0152	0.0811	CbGeAlD
Lisinopril—ACE—appendage—skin cancer	0.0136	0.0729	CbGeAlD
Lisinopril—ACE—nerve—skin cancer	0.00966	0.0517	CbGeAlD
Lisinopril—ACE2—female reproductive system—skin cancer	0.00839	0.0449	CbGeAlD
Lisinopril—ACE—endothelium—skin cancer	0.00823	0.044	CbGeAlD
Lisinopril—ACE—blood vessel—skin cancer	0.00759	0.0406	CbGeAlD
Lisinopril—ACE2—head—skin cancer	0.00701	0.0375	CbGeAlD
Lisinopril—ACE—neck—skin cancer	0.00543	0.029	CbGeAlD
Lisinopril—SLC15A1—epithelium—skin cancer	0.00515	0.0275	CbGeAlD
Lisinopril—ACE2—lymph node—skin cancer	0.00491	0.0262	CbGeAlD
Lisinopril—SLC15A1—mammalian vulva—skin cancer	0.00447	0.0239	CbGeAlD
Lisinopril—ACE—connective tissue—skin cancer	0.00389	0.0208	CbGeAlD
Lisinopril—ACE—epithelium—skin cancer	0.00369	0.0197	CbGeAlD
Lisinopril—ACE—mammalian vulva—skin cancer	0.0032	0.0171	CbGeAlD
Lisinopril—ACE—lymphoid tissue—skin cancer	0.00285	0.0152	CbGeAlD
Lisinopril—ACE—female reproductive system—skin cancer	0.00274	0.0147	CbGeAlD
Lisinopril—ABCB1—blood vessel—skin cancer	0.00267	0.0143	CbGeAlD
Lisinopril—ACE—head—skin cancer	0.00229	0.0123	CbGeAlD
Lisinopril—ACE—lymph node—skin cancer	0.00161	0.00858	CbGeAlD
Lisinopril—ABCB1—epithelium—skin cancer	0.0013	0.00695	CbGeAlD
Lisinopril—ABCB1—mammalian vulva—skin cancer	0.00113	0.00603	CbGeAlD
Lisinopril—ABCB1—lymphoid tissue—skin cancer	0.001	0.00535	CbGeAlD
Lisinopril—ABCB1—female reproductive system—skin cancer	0.000966	0.00516	CbGeAlD
Lisinopril—ABCB1—head—skin cancer	0.000807	0.00431	CbGeAlD
Lisinopril—Angiopathy—Temozolomide—skin cancer	0.000658	0.00121	CcSEcCtD
Lisinopril—Ataxia—Docetaxel—skin cancer	0.000655	0.0012	CcSEcCtD
Lisinopril—Mediastinal disorder—Temozolomide—skin cancer	0.000654	0.0012	CcSEcCtD
Lisinopril—Cough—Bleomycin—skin cancer	0.000653	0.0012	CcSEcCtD
Lisinopril—Chills—Temozolomide—skin cancer	0.000651	0.00119	CcSEcCtD
Lisinopril—Dehydration—Docetaxel—skin cancer	0.000648	0.00119	CcSEcCtD
Lisinopril—Ill-defined disorder—Dactinomycin—skin cancer	0.000648	0.00119	CcSEcCtD
Lisinopril—Anaemia—Dactinomycin—skin cancer	0.000645	0.00118	CcSEcCtD
Lisinopril—Vomiting—Vemurafenib—skin cancer	0.000641	0.00118	CcSEcCtD
Lisinopril—Alopecia—Temozolomide—skin cancer	0.000641	0.00118	CcSEcCtD
Lisinopril—Chest pain—Bleomycin—skin cancer	0.000637	0.00117	CcSEcCtD
Lisinopril—Myalgia—Bleomycin—skin cancer	0.000637	0.00117	CcSEcCtD
Lisinopril—Orthostatic hypotension—Docetaxel—skin cancer	0.000637	0.00117	CcSEcCtD
Lisinopril—Rash—Vemurafenib—skin cancer	0.000636	0.00117	CcSEcCtD
Lisinopril—Mental disorder—Temozolomide—skin cancer	0.000635	0.00117	CcSEcCtD
Lisinopril—Dermatitis—Vemurafenib—skin cancer	0.000635	0.00116	CcSEcCtD
Lisinopril—Hypersensitivity—Imiquimod—skin cancer	0.000633	0.00116	CcSEcCtD
Lisinopril—Headache—Vemurafenib—skin cancer	0.000632	0.00116	CcSEcCtD
Lisinopril—Erythema—Temozolomide—skin cancer	0.000631	0.00116	CcSEcCtD
Lisinopril—Malnutrition—Temozolomide—skin cancer	0.000631	0.00116	CcSEcCtD
Lisinopril—Breast disorder—Docetaxel—skin cancer	0.00063	0.00116	CcSEcCtD
Lisinopril—Discomfort—Bleomycin—skin cancer	0.000629	0.00115	CcSEcCtD
Lisinopril—Malaise—Dactinomycin—skin cancer	0.000629	0.00115	CcSEcCtD
Lisinopril—Cramp muscle—Docetaxel—skin cancer	0.000628	0.00115	CcSEcCtD
Lisinopril—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000628	0.00115	CcSEcCtD
Lisinopril—Leukopenia—Dactinomycin—skin cancer	0.000625	0.00115	CcSEcCtD
Lisinopril—Nasopharyngitis—Docetaxel—skin cancer	0.000623	0.00114	CcSEcCtD
Lisinopril—Dysgeusia—Temozolomide—skin cancer	0.000618	0.00113	CcSEcCtD
Lisinopril—Asthenia—Imiquimod—skin cancer	0.000617	0.00113	CcSEcCtD
Lisinopril—Confusional state—Bleomycin—skin cancer	0.000616	0.00113	CcSEcCtD
Lisinopril—Oedema—Bleomycin—skin cancer	0.000611	0.00112	CcSEcCtD
Lisinopril—Anaphylactic shock—Bleomycin—skin cancer	0.000611	0.00112	CcSEcCtD
Lisinopril—Back pain—Temozolomide—skin cancer	0.000611	0.00112	CcSEcCtD
Lisinopril—Pruritus—Imiquimod—skin cancer	0.000608	0.00112	CcSEcCtD
Lisinopril—Infection—Bleomycin—skin cancer	0.000607	0.00111	CcSEcCtD
Lisinopril—Nausea—Vemurafenib—skin cancer	0.000599	0.0011	CcSEcCtD
Lisinopril—Thrombocytopenia—Bleomycin—skin cancer	0.000598	0.0011	CcSEcCtD
Lisinopril—Arrhythmia—Fluorouracil—skin cancer	0.000597	0.00109	CcSEcCtD
Lisinopril—Vision blurred—Temozolomide—skin cancer	0.000595	0.00109	CcSEcCtD
Lisinopril—Myalgia—Dactinomycin—skin cancer	0.000594	0.00109	CcSEcCtD
Lisinopril—Bronchospasm—Docetaxel—skin cancer	0.000593	0.00109	CcSEcCtD
Lisinopril—Tremor—Temozolomide—skin cancer	0.000591	0.00108	CcSEcCtD
Lisinopril—Alopecia—Fluorouracil—skin cancer	0.00059	0.00108	CcSEcCtD
Lisinopril—Diarrhoea—Imiquimod—skin cancer	0.000588	0.00108	CcSEcCtD
Lisinopril—Discomfort—Dactinomycin—skin cancer	0.000587	0.00108	CcSEcCtD
Lisinopril—Angina pectoris—Docetaxel—skin cancer	0.000587	0.00108	CcSEcCtD
Lisinopril—Ill-defined disorder—Temozolomide—skin cancer	0.000586	0.00107	CcSEcCtD
Lisinopril—Anaemia—Temozolomide—skin cancer	0.000583	0.00107	CcSEcCtD
Lisinopril—Anorexia—Bleomycin—skin cancer	0.000582	0.00107	CcSEcCtD
Lisinopril—Erythema—Fluorouracil—skin cancer	0.000582	0.00107	CcSEcCtD
Lisinopril—Angioedema—Temozolomide—skin cancer	0.000577	0.00106	CcSEcCtD
Lisinopril—Pancytopenia—Docetaxel—skin cancer	0.000572	0.00105	CcSEcCtD
Lisinopril—Hypotension—Bleomycin—skin cancer	0.000571	0.00105	CcSEcCtD
Lisinopril—Oedema—Dactinomycin—skin cancer	0.00057	0.00104	CcSEcCtD
Lisinopril—Malaise—Temozolomide—skin cancer	0.000569	0.00104	CcSEcCtD
Lisinopril—Dizziness—Imiquimod—skin cancer	0.000568	0.00104	CcSEcCtD
Lisinopril—Vertigo—Temozolomide—skin cancer	0.000567	0.00104	CcSEcCtD
Lisinopril—Infection—Dactinomycin—skin cancer	0.000566	0.00104	CcSEcCtD
Lisinopril—ABCB1—lymph node—skin cancer	0.000565	0.00302	CbGeAlD
Lisinopril—Leukopenia—Temozolomide—skin cancer	0.000565	0.00104	CcSEcCtD
Lisinopril—Neutropenia—Docetaxel—skin cancer	0.000563	0.00103	CcSEcCtD
Lisinopril—Palpitations—Temozolomide—skin cancer	0.000558	0.00102	CcSEcCtD
Lisinopril—Thrombocytopenia—Dactinomycin—skin cancer	0.000558	0.00102	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000556	0.00102	CcSEcCtD
Lisinopril—Cough—Temozolomide—skin cancer	0.000551	0.00101	CcSEcCtD
Lisinopril—Paraesthesia—Bleomycin—skin cancer	0.000548	0.00101	CcSEcCtD
Lisinopril—Weight increased—Docetaxel—skin cancer	0.000548	0.00101	CcSEcCtD
Lisinopril—Vision blurred—Fluorouracil—skin cancer	0.000548	0.00101	CcSEcCtD
Lisinopril—Vomiting—Imiquimod—skin cancer	0.000547	0.001	CcSEcCtD
Lisinopril—Weight decreased—Docetaxel—skin cancer	0.000545	0.001	CcSEcCtD
Lisinopril—Dyspnoea—Bleomycin—skin cancer	0.000544	0.000999	CcSEcCtD
Lisinopril—Anorexia—Dactinomycin—skin cancer	0.000543	0.000996	CcSEcCtD
Lisinopril—Rash—Imiquimod—skin cancer	0.000542	0.000994	CcSEcCtD
Lisinopril—Dermatitis—Imiquimod—skin cancer	0.000542	0.000993	CcSEcCtD
Lisinopril—Pneumonia—Docetaxel—skin cancer	0.00054	0.000991	CcSEcCtD
Lisinopril—Headache—Imiquimod—skin cancer	0.000539	0.000988	CcSEcCtD
Lisinopril—Anaemia—Fluorouracil—skin cancer	0.000538	0.000986	CcSEcCtD
Lisinopril—Arthralgia—Temozolomide—skin cancer	0.000537	0.000986	CcSEcCtD
Lisinopril—Myalgia—Temozolomide—skin cancer	0.000537	0.000986	CcSEcCtD
Lisinopril—Anxiety—Temozolomide—skin cancer	0.000536	0.000982	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000534	0.000979	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000533	0.000977	CcSEcCtD
Lisinopril—Discomfort—Temozolomide—skin cancer	0.000531	0.000974	CcSEcCtD
Lisinopril—Decreased appetite—Bleomycin—skin cancer	0.000531	0.000974	CcSEcCtD
Lisinopril—Acute coronary syndrome—Docetaxel—skin cancer	0.00053	0.000971	CcSEcCtD
Lisinopril—Renal failure—Docetaxel—skin cancer	0.000528	0.000968	CcSEcCtD
Lisinopril—Myocardial infarction—Docetaxel—skin cancer	0.000527	0.000966	CcSEcCtD
Lisinopril—Neuropathy peripheral—Docetaxel—skin cancer	0.000527	0.000966	CcSEcCtD
Lisinopril—Dry mouth—Temozolomide—skin cancer	0.000526	0.000964	CcSEcCtD
Lisinopril—Jaundice—Docetaxel—skin cancer	0.000524	0.00096	CcSEcCtD
Lisinopril—Pain—Bleomycin—skin cancer	0.000522	0.000958	CcSEcCtD
Lisinopril—Leukopenia—Fluorouracil—skin cancer	0.000521	0.000955	CcSEcCtD
Lisinopril—Confusional state—Temozolomide—skin cancer	0.000519	0.000953	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000519	0.000952	CcSEcCtD
Lisinopril—Oedema—Temozolomide—skin cancer	0.000515	0.000945	CcSEcCtD
Lisinopril—Anaphylactic shock—Temozolomide—skin cancer	0.000515	0.000945	CcSEcCtD
Lisinopril—Infection—Temozolomide—skin cancer	0.000512	0.000939	CcSEcCtD
Lisinopril—Nausea—Imiquimod—skin cancer	0.000511	0.000936	CcSEcCtD
Lisinopril—Hepatobiliary disease—Docetaxel—skin cancer	0.000508	0.000932	CcSEcCtD
Lisinopril—Epistaxis—Docetaxel—skin cancer	0.000507	0.000929	CcSEcCtD
Lisinopril—Thrombocytopenia—Temozolomide—skin cancer	0.000504	0.000925	CcSEcCtD
Lisinopril—Feeling abnormal—Bleomycin—skin cancer	0.000503	0.000923	CcSEcCtD
Lisinopril—Agranulocytosis—Docetaxel—skin cancer	0.000501	0.000919	CcSEcCtD
Lisinopril—Skin disorder—Temozolomide—skin cancer	0.0005	0.000918	CcSEcCtD
Lisinopril—Hyperhidrosis—Temozolomide—skin cancer	0.000498	0.000913	CcSEcCtD
Lisinopril—Chest pain—Fluorouracil—skin cancer	0.000495	0.000908	CcSEcCtD
Lisinopril—Myalgia—Fluorouracil—skin cancer	0.000495	0.000908	CcSEcCtD
Lisinopril—Decreased appetite—Dactinomycin—skin cancer	0.000495	0.000908	CcSEcCtD
Lisinopril—Fatigue—Dactinomycin—skin cancer	0.000491	0.000901	CcSEcCtD
Lisinopril—Anorexia—Temozolomide—skin cancer	0.000491	0.000901	CcSEcCtD
Lisinopril—Discomfort—Fluorouracil—skin cancer	0.000489	0.000897	CcSEcCtD
Lisinopril—Pain—Dactinomycin—skin cancer	0.000487	0.000893	CcSEcCtD
Lisinopril—Urticaria—Bleomycin—skin cancer	0.000485	0.00089	CcSEcCtD
Lisinopril—Rhinitis—Docetaxel—skin cancer	0.000483	0.000887	CcSEcCtD
Lisinopril—Body temperature increased—Bleomycin—skin cancer	0.000483	0.000885	CcSEcCtD
Lisinopril—Hepatitis—Docetaxel—skin cancer	0.000482	0.000884	CcSEcCtD
Lisinopril—Confusional state—Fluorouracil—skin cancer	0.000479	0.000878	CcSEcCtD
Lisinopril—Pharyngitis—Docetaxel—skin cancer	0.000479	0.000878	CcSEcCtD
Lisinopril—Urinary tract disorder—Docetaxel—skin cancer	0.000476	0.000873	CcSEcCtD
Lisinopril—Oedema peripheral—Docetaxel—skin cancer	0.000475	0.000871	CcSEcCtD
Lisinopril—Oedema—Fluorouracil—skin cancer	0.000475	0.000871	CcSEcCtD
Lisinopril—Anaphylactic shock—Fluorouracil—skin cancer	0.000475	0.000871	CcSEcCtD
Lisinopril—Urethral disorder—Docetaxel—skin cancer	0.000473	0.000867	CcSEcCtD
Lisinopril—Infection—Fluorouracil—skin cancer	0.000472	0.000865	CcSEcCtD
Lisinopril—Feeling abnormal—Dactinomycin—skin cancer	0.000469	0.000861	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000469	0.000861	CcSEcCtD
Lisinopril—Insomnia—Temozolomide—skin cancer	0.000466	0.000855	CcSEcCtD
Lisinopril—Gastrointestinal pain—Dactinomycin—skin cancer	0.000466	0.000854	CcSEcCtD
Lisinopril—Thrombocytopenia—Fluorouracil—skin cancer	0.000465	0.000852	CcSEcCtD
Lisinopril—Tachycardia—Fluorouracil—skin cancer	0.000463	0.00085	CcSEcCtD
Lisinopril—Paraesthesia—Temozolomide—skin cancer	0.000463	0.000848	CcSEcCtD
Lisinopril—Dyspnoea—Temozolomide—skin cancer	0.000459	0.000842	CcSEcCtD
Lisinopril—Somnolence—Temozolomide—skin cancer	0.000458	0.00084	CcSEcCtD
Lisinopril—Erythema multiforme—Docetaxel—skin cancer	0.000456	0.000836	CcSEcCtD
Lisinopril—Dyspepsia—Temozolomide—skin cancer	0.000453	0.000832	CcSEcCtD
Lisinopril—Anorexia—Fluorouracil—skin cancer	0.000452	0.00083	CcSEcCtD
Lisinopril—Body temperature increased—Dactinomycin—skin cancer	0.00045	0.000826	CcSEcCtD
Lisinopril—Abdominal pain—Dactinomycin—skin cancer	0.00045	0.000826	CcSEcCtD
Lisinopril—Hypersensitivity—Bleomycin—skin cancer	0.00045	0.000825	CcSEcCtD
Lisinopril—Decreased appetite—Temozolomide—skin cancer	0.000448	0.000821	CcSEcCtD
Lisinopril—Flushing—Docetaxel—skin cancer	0.000448	0.000821	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Temozolomide—skin cancer	0.000445	0.000816	CcSEcCtD
Lisinopril—Fatigue—Temozolomide—skin cancer	0.000444	0.000815	CcSEcCtD
Lisinopril—Hypotension—Fluorouracil—skin cancer	0.000444	0.000813	CcSEcCtD
Lisinopril—Constipation—Temozolomide—skin cancer	0.000441	0.000808	CcSEcCtD
Lisinopril—Pain—Temozolomide—skin cancer	0.000441	0.000808	CcSEcCtD
Lisinopril—Asthenia—Bleomycin—skin cancer	0.000438	0.000804	CcSEcCtD
Lisinopril—Angiopathy—Docetaxel—skin cancer	0.000438	0.000802	CcSEcCtD
Lisinopril—Mediastinal disorder—Docetaxel—skin cancer	0.000435	0.000797	CcSEcCtD
Lisinopril—Chills—Docetaxel—skin cancer	0.000433	0.000794	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000432	0.000793	CcSEcCtD
Lisinopril—Pruritus—Bleomycin—skin cancer	0.000432	0.000792	CcSEcCtD
Lisinopril—Arrhythmia—Docetaxel—skin cancer	0.000431	0.00079	CcSEcCtD
Lisinopril—Insomnia—Fluorouracil—skin cancer	0.000429	0.000787	CcSEcCtD
Lisinopril—Paraesthesia—Fluorouracil—skin cancer	0.000426	0.000782	CcSEcCtD
Lisinopril—Alopecia—Docetaxel—skin cancer	0.000426	0.000781	CcSEcCtD
Lisinopril—Feeling abnormal—Temozolomide—skin cancer	0.000425	0.000779	CcSEcCtD
Lisinopril—Dyspnoea—Fluorouracil—skin cancer	0.000423	0.000776	CcSEcCtD
Lisinopril—Mental disorder—Docetaxel—skin cancer	0.000422	0.000775	CcSEcCtD
Lisinopril—Somnolence—Fluorouracil—skin cancer	0.000422	0.000774	CcSEcCtD
Lisinopril—Gastrointestinal pain—Temozolomide—skin cancer	0.000421	0.000773	CcSEcCtD
Lisinopril—Erythema—Docetaxel—skin cancer	0.00042	0.00077	CcSEcCtD
Lisinopril—Malnutrition—Docetaxel—skin cancer	0.00042	0.00077	CcSEcCtD
Lisinopril—Hypersensitivity—Dactinomycin—skin cancer	0.00042	0.00077	CcSEcCtD
Lisinopril—Dyspepsia—Fluorouracil—skin cancer	0.000418	0.000766	CcSEcCtD
Lisinopril—Decreased appetite—Fluorouracil—skin cancer	0.000413	0.000757	CcSEcCtD
Lisinopril—Dysgeusia—Docetaxel—skin cancer	0.000411	0.000754	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00041	0.000752	CcSEcCtD
Lisinopril—Urticaria—Temozolomide—skin cancer	0.000409	0.000751	CcSEcCtD
Lisinopril—Asthenia—Dactinomycin—skin cancer	0.000409	0.000749	CcSEcCtD
Lisinopril—Body temperature increased—Temozolomide—skin cancer	0.000407	0.000747	CcSEcCtD
Lisinopril—Abdominal pain—Temozolomide—skin cancer	0.000407	0.000747	CcSEcCtD
Lisinopril—Back pain—Docetaxel—skin cancer	0.000406	0.000745	CcSEcCtD
Lisinopril—Pain—Fluorouracil—skin cancer	0.000406	0.000744	CcSEcCtD
Lisinopril—Muscle spasms—Docetaxel—skin cancer	0.000404	0.00074	CcSEcCtD
Lisinopril—Feeling abnormal—Fluorouracil—skin cancer	0.000391	0.000717	CcSEcCtD
Lisinopril—Diarrhoea—Dactinomycin—skin cancer	0.00039	0.000715	CcSEcCtD
Lisinopril—Vomiting—Bleomycin—skin cancer	0.000388	0.000712	CcSEcCtD
Lisinopril—Anaemia—Docetaxel—skin cancer	0.000388	0.000712	CcSEcCtD
Lisinopril—Rash—Bleomycin—skin cancer	0.000385	0.000706	CcSEcCtD
Lisinopril—Dermatitis—Bleomycin—skin cancer	0.000385	0.000706	CcSEcCtD
Lisinopril—Hypersensitivity—Temozolomide—skin cancer	0.00038	0.000696	CcSEcCtD
Lisinopril—Urticaria—Fluorouracil—skin cancer	0.000377	0.000692	CcSEcCtD
Lisinopril—Syncope—Docetaxel—skin cancer	0.000376	0.00069	CcSEcCtD
Lisinopril—Leukopenia—Docetaxel—skin cancer	0.000376	0.000689	CcSEcCtD
Lisinopril—Body temperature increased—Fluorouracil—skin cancer	0.000375	0.000688	CcSEcCtD
Lisinopril—Palpitations—Docetaxel—skin cancer	0.000371	0.00068	CcSEcCtD
Lisinopril—Asthenia—Temozolomide—skin cancer	0.00037	0.000678	CcSEcCtD
Lisinopril—Loss of consciousness—Docetaxel—skin cancer	0.000369	0.000677	CcSEcCtD
Lisinopril—Cough—Docetaxel—skin cancer	0.000366	0.000672	CcSEcCtD
Lisinopril—Pruritus—Temozolomide—skin cancer	0.000364	0.000668	CcSEcCtD
Lisinopril—Nausea—Bleomycin—skin cancer	0.000363	0.000665	CcSEcCtD
Lisinopril—Vomiting—Dactinomycin—skin cancer	0.000362	0.000664	CcSEcCtD
Lisinopril—Rash—Dactinomycin—skin cancer	0.000359	0.000659	CcSEcCtD
Lisinopril—Myalgia—Docetaxel—skin cancer	0.000357	0.000655	CcSEcCtD
Lisinopril—Chest pain—Docetaxel—skin cancer	0.000357	0.000655	CcSEcCtD
Lisinopril—Arthralgia—Docetaxel—skin cancer	0.000357	0.000655	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000355	0.000651	CcSEcCtD
Lisinopril—Diarrhoea—Temozolomide—skin cancer	0.000352	0.000646	CcSEcCtD
Lisinopril—Hypersensitivity—Fluorouracil—skin cancer	0.00035	0.000641	CcSEcCtD
Lisinopril—Dry mouth—Docetaxel—skin cancer	0.00035	0.000641	CcSEcCtD
Lisinopril—Confusional state—Docetaxel—skin cancer	0.000345	0.000634	CcSEcCtD
Lisinopril—Anaphylactic shock—Docetaxel—skin cancer	0.000343	0.000628	CcSEcCtD
Lisinopril—Oedema—Docetaxel—skin cancer	0.000343	0.000628	CcSEcCtD
Lisinopril—Dizziness—Temozolomide—skin cancer	0.000341	0.000625	CcSEcCtD
Lisinopril—Infection—Docetaxel—skin cancer	0.00034	0.000624	CcSEcCtD
Lisinopril—Nausea—Dactinomycin—skin cancer	0.000338	0.00062	CcSEcCtD
Lisinopril—Shock—Docetaxel—skin cancer	0.000337	0.000618	CcSEcCtD
Lisinopril—Pruritus—Fluorouracil—skin cancer	0.000336	0.000616	CcSEcCtD
Lisinopril—Thrombocytopenia—Docetaxel—skin cancer	0.000335	0.000615	CcSEcCtD
Lisinopril—Tachycardia—Docetaxel—skin cancer	0.000334	0.000613	CcSEcCtD
Lisinopril—Skin disorder—Docetaxel—skin cancer	0.000333	0.00061	CcSEcCtD
Lisinopril—Vomiting—Temozolomide—skin cancer	0.000328	0.000601	CcSEcCtD
Lisinopril—Anorexia—Docetaxel—skin cancer	0.000327	0.000599	CcSEcCtD
Lisinopril—Rash—Temozolomide—skin cancer	0.000325	0.000596	CcSEcCtD
Lisinopril—Diarrhoea—Fluorouracil—skin cancer	0.000325	0.000596	CcSEcCtD
Lisinopril—Dermatitis—Temozolomide—skin cancer	0.000325	0.000595	CcSEcCtD
Lisinopril—Headache—Temozolomide—skin cancer	0.000323	0.000592	CcSEcCtD
Lisinopril—Hypotension—Docetaxel—skin cancer	0.00032	0.000587	CcSEcCtD
Lisinopril—Dizziness—Fluorouracil—skin cancer	0.000314	0.000576	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000312	0.000572	CcSEcCtD
Lisinopril—Insomnia—Docetaxel—skin cancer	0.00031	0.000568	CcSEcCtD
Lisinopril—Paraesthesia—Docetaxel—skin cancer	0.000308	0.000564	CcSEcCtD
Lisinopril—Nausea—Temozolomide—skin cancer	0.000306	0.000561	CcSEcCtD
Lisinopril—Dyspnoea—Docetaxel—skin cancer	0.000305	0.00056	CcSEcCtD
Lisinopril—Somnolence—Docetaxel—skin cancer	0.000305	0.000559	CcSEcCtD
Lisinopril—Vomiting—Fluorouracil—skin cancer	0.000302	0.000553	CcSEcCtD
Lisinopril—Dyspepsia—Docetaxel—skin cancer	0.000302	0.000553	CcSEcCtD
Lisinopril—Rash—Fluorouracil—skin cancer	0.000299	0.000549	CcSEcCtD
Lisinopril—Dermatitis—Fluorouracil—skin cancer	0.000299	0.000548	CcSEcCtD
Lisinopril—Decreased appetite—Docetaxel—skin cancer	0.000298	0.000546	CcSEcCtD
Lisinopril—Headache—Fluorouracil—skin cancer	0.000297	0.000545	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Docetaxel—skin cancer	0.000296	0.000542	CcSEcCtD
Lisinopril—Fatigue—Docetaxel—skin cancer	0.000295	0.000542	CcSEcCtD
Lisinopril—Pain—Docetaxel—skin cancer	0.000293	0.000537	CcSEcCtD
Lisinopril—Constipation—Docetaxel—skin cancer	0.000293	0.000537	CcSEcCtD
Lisinopril—Feeling abnormal—Docetaxel—skin cancer	0.000282	0.000518	CcSEcCtD
Lisinopril—Nausea—Fluorouracil—skin cancer	0.000282	0.000517	CcSEcCtD
Lisinopril—Gastrointestinal pain—Docetaxel—skin cancer	0.00028	0.000514	CcSEcCtD
Lisinopril—Abdominal pain—Docetaxel—skin cancer	0.000271	0.000497	CcSEcCtD
Lisinopril—Body temperature increased—Docetaxel—skin cancer	0.000271	0.000497	CcSEcCtD
Lisinopril—Hypersensitivity—Docetaxel—skin cancer	0.000252	0.000463	CcSEcCtD
Lisinopril—Asthenia—Docetaxel—skin cancer	0.000246	0.000451	CcSEcCtD
Lisinopril—Pruritus—Docetaxel—skin cancer	0.000242	0.000445	CcSEcCtD
Lisinopril—Diarrhoea—Docetaxel—skin cancer	0.000234	0.00043	CcSEcCtD
Lisinopril—Dizziness—Docetaxel—skin cancer	0.000227	0.000415	CcSEcCtD
Lisinopril—Vomiting—Docetaxel—skin cancer	0.000218	0.000399	CcSEcCtD
Lisinopril—Rash—Docetaxel—skin cancer	0.000216	0.000396	CcSEcCtD
Lisinopril—Dermatitis—Docetaxel—skin cancer	0.000216	0.000396	CcSEcCtD
Lisinopril—Headache—Docetaxel—skin cancer	0.000215	0.000394	CcSEcCtD
Lisinopril—Nausea—Docetaxel—skin cancer	0.000204	0.000373	CcSEcCtD
